Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians

Journal of Lipid Research

Volumn 43, Issue 2, 2002, Pages 234-244

  Rubin, Jill ^a   Paultre, Furcy ^a   Tuck, Catherine H ^a   Holleran, Steve ^a   Reed, Roberta G ^b   Pearson, Thomas A ^b,c   Thomas, Christopher M ^d   Ramakrishnan, Rajasekhar ^a   Berglund, Lars ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b BASSETT RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Coronary artery disease; Genetics; Lipoprotein a ; Lipoproteins; Risk factors

Indexed keywords

APOLIPOPROTEIN A; ISOPROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; DOMINANT INHERITANCE; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; MOLECULAR INTERACTION; NEGRO; NORMAL HUMAN; POPULATION GENETICS; PRIORITY JOURNAL; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; APOLIPOPROTEINS A; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENES, DOMINANT; GENOTYPE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PROTEIN ISOFORMS;

EID: 0036189436     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Lp[a] lipoprotein as a risk factor for myocardial infarction
2. Association of levels of lipoprotein Lp[a], plasma lipids, and other lipoproteins with coronary artery disease documented by angiography
3. Lipoprotein Lp[a] and the risk for myocardial infarction
4. Serum Lp[a] as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men
5. A prospective investigation of elevated lipoprotein [a] detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study
6. Lipoprotein [a] and risk of coronary heart disease in men: The lipid research clinic coronary primary prevention trial
7. Elevated plasma lipoprotein [a] and coronary heart disease in men aged 55 years and younger: A prospective study
8. A prospective case-control study of lipoprotein [a] levels and apo [a] size and risk of coronary heart disease in Stanford Five-City Project participants
9. Predictive value of electrophoretically detected lipoprotein [a] for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women
10. Lipoprotein Lp[a] excess and coronary heart disease
11. Lipoprotein[a] and coronary heart disease. Meta-analysis of prospective studies
12. cDNA sequence of human apolipoprotein[a] is homologous to plasminogen
13. The mysteries of lipoprotein[a]
14. Apolipoprotein [a] gene accounts for greater than 90% of the variation in plasma lipoprotein[a] concentrations
15. Plasma Lp[a] concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo[a] gene
16. Apolipoprotein [a] size heterogeneity is related to variable number of repeat sequences in its mRNA
17. Comparative analysis of the apo[a] gene, apo[a] glycoprotein, and plasma concentration of Lp[a] in three ethnic groups. Evidence for no common "null" allele at the apo[a] locus
18. Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes
19. Molecular basis for the 'null' lipoprotein [a] phenotypes and the influence of apolipoprotein [a] size on plasma lipoprotein [a] levels in the baboon
20. Cell surface assembly of lipoprotein[a] in primary cultures of baboon hepatocytes
21. Presecretory degradation of apolipoprotein[a] is mediated by the proteosome pathway
22. The number of identical kringle IV repeats in apolipoprotein[a] affects its processing and secretion by HepG2 cells
23. Intracellular metabolism of human apolipoprotein[a] in stably transfected Hep G2 cells
24. Role of N-linked glycans, chaperone interactions and proteasomes in the intracellular targeting of apolipoprotein[a]
25. Lipoprotein[a] and apolipoprotein [a] phenotypes in C and AA: The CARDIA Study
26. Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans
27. The apo[a] gene is the major determinant of variation in plasma Lp[a] levels in AA
28. C/T polymorphism in the 5′ untranslated region of the apolipoprotein[a] gene introduces an upstream ATG and reduces in vitro translation
29. Sequence polymorphisms in the apo[a] gene associated with specific levels of Lp[a] in plasma
30. A pentanucleotide repeat polymorphism in the 5′ control region of the apolipoprotein [a] gene is associated with lipoprotein [a] plasma concentrations in C
31. Significant impact of the +93 C/T polymorphism in the apolipoprotein [a] gene on Lp[a] concentrations in African but not in C: Confounding effect of linkage disequilibrium
32. Apolipoprotein[a] kringle IV repeat number predicts risk for coronary artery disease
33. Association between apolipoprotein[a] phenotypes and coronary heart disease at a young age
34. Lp[a] concentration and apo[a] isoform size: Relation to the presence of coronary artery disease in familial hypercholesterolemia
35. Relation of serum lipoprotein[a] concentration and apolipoprotein[a] phenotype to coronary heart disease in patients with familial hypercholesterolemia
36. Association of elevated lipoprotein[a] levels and coronary heart disease in NIDDM patients: Relationship with apolipoprotein[a] phenotypes
37. Evidence that apolipoprotein[a] phenotype is a risk factor for coronary artery disease in men <55 years of age
38. Serum lipids, lipoprotein[a] and apo[a] isoforms in patients with established coronary artery disease and their regulation to disease and prognosis after coronary by-pass surgery
39. Significant association between low-molecular-weight apolipoprotein[a] isoforms and intermittent claudication
40. High levels of lipoprotein[a] carrying a small apolipoprotein[a] isoform is associated with coronary artery disease in both AA and C men
41. Race-related differences among patients with left ventricular dysfunction: Observations from a biracial angiographic cohort. Harlem-Bassett LP[a] Investigators
42. Molecular basis of apolipoprotein[a] isoform size heterogeneity as revealed by pulsed-field electrophoresis
43. Molecular definition of the extreme size polymorphism in apolipoprotein[a]
44. Expressed hypervariable polymorphism of apolipoprotein[a]
45. Relation between number of apolipoprotein[a] kringle 4 repeats and mobility of isoforms in agarose gel: Basis for a standardized isoform nomenclature
46. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study
47. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys
48. Genetic control of lipoprotein[a] concentrations is different in Africans and C
49. Apolipoprotein[a] (Apo[a]) glycoprotein isoforms result from size differences in apo[a] mRNA in baboons
50. Several liver specific DNAse hypersensitive sites are present in the intergenic region separating human plasminogen and apoprotein[a] genes
51. Characterization of multiple enhancer regions upstream of the apolipoprotein[a] gene
52. Predictors of plasma lipoprotein[a] concentration in the West of Scotland Coronary Prevention Study cohort
53. Variation in Lipoprotein[a] concentration associated with different apolipoprotein[a] alleles
54. Detection and qauntitation of apolipoprotein[a] mRNA in human liver and its relationship with plasma lipoprotein[a] concentration
55. The inverse association of plasma lipoprotein concentrations with apolipoprotein[a] isoform size is not due to differences in Lp[a] catabolism but to differences in production rate
56. Variation in lipoprotein[a] concentrations among individuals with the same apolipoprotein[a] isofom is determined by the rate of lipoprotein[a] production
57. Turnover of Lipoprotein[a] in man